Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
April 3, 2006
- Takeda to Emphasize Concept-based R&D Model
April 3, 2006
- SURVEY 2 articles
April 3, 2006
- Astellas Licenses Anti-Human Osteopontin Antibodies from IBL
April 3, 2006
- Eli Lilly to Enter GP Market with Tadalafil: President Crenshaw
April 3, 2006
- Toyama's T-705 Effective Against Avian Flu in Early Testing
April 3, 2006
- US Subsidiaries of Daiichi, Sankyo to Integrate Operations
April 3, 2006
- Janus Initiates PII Trial of Topical Herpes Zoster Treatment in US
April 3, 2006
- Worldwide Production of Tamiflu Expanded to 400 Mil. Treatments: Chugai
April 3, 2006
- CytoPathfinder, Santen to Do Joint Research for Ophthalmic Drugs
April 3, 2006
- BUSINESS NEWS IN BRIEF
April 3, 2006
- PMDA to Propose Policy Regarding Int'l Joint Clinical Trials
April 3, 2006
- Dispensing Fee Revision to Hit Major Dispensing Pharmacies: JPA
April 3, 2006
- Japan Should Participate in Global Trials from an Early Stage: Mr Mori of PMDA
April 3, 2006
- JPA's Top Priority Projects Outlined by Mr Ishii
April 3, 2006
- R&D NEWS IN BRIEF
April 3, 2006
- Hodanren Submits Petition on NHI Pricing, Medical Fees
April 3, 2006
- SEMINAR
April 3, 2006
- Meeting of Prefectural Pharm. Affairs Managers
April 3, 2006
- Aricept Improves Cognitive Function in Vascular Dementia: Eisai
March 27, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…